3 years ago
FATE
AnalystsRobert BurnsRobert Burns's Stock Forecasts
AnalystsRobert Burns
Sectors:
Industries:
Analyst Ranking
Top 5%
#250 out of 5253 analysts
Average Return
+6.56%
Win Rate
42%249 out of 590
Risk vs Reward
Poor
Good
Robert Burns's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Tango Therapeutics IncTNGX | +1,388.81% | $1.34 | $19.95 | 2025-04-13 - 2026-04-10 | Buy |
Prelude Therapeutics IncPRLD | +620.13% | $0.61 | $4.40 | 2025-04-07 - 2026-04-07 | Buy |
Cogent Biosciences IncCOGT | +581.54% | $5.31 | $36.19 | 2025-05-19 - 2026-04-16 | Buy |
Tuhura Biosciences IncHURA | +533.83% | $0.47 | $2.96 | 2026-02-02 - 2026-04-16 | Buy |
Prelude Therapeutics IncPRLD | +438.93% | $0.82 | $4.43 | 2025-05-04 - 2026-04-16 | Buy |
Robert Burns Analyst Color
Get additional color on Robert Burns's coverage of popular stocks
Robert Burns's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Allogene Therapeutics IncALLO | 16 | Buy | $11.00 | +364.14% | Maintains | a day ago |
Revolution Medicines IncRVMD | 20 | Buy | $169.00 | +13.22% | Maintains | 3 days ago |
Telix Pharmaceuticals LtdTLX | 6 | Buy | $20.00 | +86.22% | Reiterates | 4 days ago |
Nurix Therapeutics IncNRIX | 23 | Buy | $32.00 | +91.73% | Reiterates | 7 days ago |
Caribou Biosciences IncCRBU | 16 | Buy | $9.00 | +318.60% | Reiterates | 10 days ago |
Oric Pharmaceuticals IncORIC | 29 | Buy | $25.00 | +144.38% | Reiterates | 15 days ago |
Biontech SeBNTX | 45 | Buy | $130.00 | +27.30% | Maintains | 17 days ago |
Aktis Oncology IncAKTS | 2 | Buy | $33.00 | +77.42% | Maintains | 17 days ago |
Bicara Therapeutics IncBCAX | 6 | Buy | $42.00 | +75.51% | Maintains | 17 days ago |
IMMIX Biopharma IncIMMX | 12 | Buy | $15.00 | +50.60% | Reiterates | 18 days ago |
Enliven Therapeutics IncELVN | 6 | Buy | $56.00 | +23.51% | Maintains | 22 days ago |
Karyopharm Therapeutics IncKPTI | 4 | Buy | $8.00 | -7.62% | Maintains | 23 days ago |
Adicet Bio IncACET | 4 | Buy | $27.00 | +235.40% | Maintains | 25 days ago |
Relay Therapeutics IncRLAY | 22 | Buy | $19.00 | +17.94% | Maintains | 25 days ago |
Adc Therapeutics SaADCT | 20 | Buy | $8.00 | +82.65% | Maintains | 25 days ago |
Perspective Therapeutics IncCATX | 7 | Buy | $13.00 | +205.16% | Maintains | 25 days ago |
Onkure Therapeutics IncOKUR | 5 | Buy | $27.00 | +478.16% | Maintains | a month ago |
Molecular Partners AgMOLN | 3 | Buy | $13.00 | +211.00% | Reiterates | a month ago |
Elicio Therapeutics IncELTX | 9 | Buy | $17.00 | +34.92% | Maintains | a month ago |
Bolt Biotherapeutics IncBOLT | 2 | Buy | $7.00 | +45.53% | Reiterates | a month ago |
Arrivent Biopharma IncAVBP | 12 | Buy | $44.00 | +48.60% | Maintains | a month ago |
Bridgebio Oncology Therapeutics IncBBOT | 2 | Buy | $29.00 | +214.53% | Maintains | a month ago |
Tango Therapeutics IncTNGX | 13 | Buy | $27.00 | +7.83% | Maintains | a month ago |
Zymeworks IncZYME | 24 | Buy | $46.00 | +69.12% | Maintains | a month ago |
Exelixis IncEXEL | 15 | Buy | $54.00 | +21.68% | Maintains | 2 months ago |
Tuhura Biosciences IncHURA | 5 | Buy | $10.00 | +237.84% | Reiterates | 2 months ago |
Cardiff Oncology IncCRDF | 4 | Buy | $10.00 | +491.72% | Reiterates | 3 months ago |
Nuvation Bio IncNUVB | 18 | Buy | $17.00 | +253.43% | Maintains | 3 months ago |
Cullinan Therapeutics IncCGEM | 4 | Buy | $27.00 | +83.18% | Maintains | 3 months ago |
Cogent Biosciences IncCOGT | 15 | Buy | $52.00 | +43.69% | Maintains | 3 months ago |
Macrogenics IncMGNX | 19 | Hold | $2.00 | -41.35% | Reiterates | 5 months ago |
Fate Therapeutics IncFATE | 7 | Buy | $5.00 | +264.96% | Upgrades | 6 months ago |
Repare Therapeutics IncRPTX | 19 | Buy | $3.00 | +13.21% | Maintains | 6 months ago |
Replimune Group IncREPL | 17 | Buy | $12.00 | +447.95% | Upgrades | 6 months ago |
Prelude Therapeutics IncPRLD | 17 | Buy | $5.00 | +12.87% | Reiterates | 7 months ago |
Black Diamond Therapeutics IncBDTX | 14 | Buy | $10.00 | +242.47% | Maintains | 8 months ago |
Y Mabs Therapeutics IncYMAB | 15 | Hold | $8.60 | -0.12% | Downgrades | 8 months ago |
Springworks Therapeutics IncSWTX | 29 | Hold | $47.00 | +0.02% | Downgrades | a year ago |
Pmv Pharmaceuticals IncPMVP | 11 | Buy | $5.00 | N/A | Reiterates | a year ago |
Cargo Therapeutics IncCRGX | 3 | Buy | $33.00 | N/A | Reiterates | a year ago |
Igm Biosciences IncIGMS | 13 | Hold | $11.00 | N/A | Maintains | 2 years ago |
Kronos Bio IncKRON | 10 | Buy | $2.25 | N/A | Reiterates | 2 years ago |
Omega Therapeutics IncOMGAQ | 9 | Buy | $12.00 | N/A | Reiterates | 2 years ago |
Apollomics IncAPLM | 5 | Buy | $200.00 | N/A | Maintains | 2 years ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $4.00 | N/A | Reiterates | 2 years ago |
Effector Therapeutics IncEFTR | 3 | Buy | $24.00 | N/A | Reiterates | 2 years ago |
Calidi Biotherapeutics IncCLDI | 2 | Buy | $240.00 | N/A | Maintains | 2 years ago |
Kineta IncKANT | 4 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
Alphaton Capital CorpATON | 5 | Buy | $120.00 | N/A | Maintains | 2 years ago |
Whitehawk Therapeutics IncWHWK | 9 | Buy | $36.00 | N/A | Maintains | 2 years ago |
Kinnate Biopharma IncKNTE | 6 | Buy | $24.00 | N/A | Reiterates | 3 years ago |
Gt Biopharma IncGTBP | 6 | Buy | $150.00 | N/A | Reiterates | 3 years ago |
Atara Biotherapeutics IncATRA | 8 | Buy | $700.00 | N/A | Maintains | 3 years ago |
Imagenebio IncIMA | 4 | Buy | $264.00 | N/A | Reiterates | 3 years ago |
Tcr2 Therapeutics IncTCRR | 4 | Buy | $13.00 | N/A | Maintains | 3 years ago |
Neurogene IncNGNE | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | N/A | Downgrades | 4 years ago |
Turning Point Therapeutics IncTPTX | 6 | Hold | $76.00 | N/A | Downgrades | 4 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $11.00 | N/A | Maintains | 4 years ago |
Nucana PLCNCNA | 7 | Buy | $45,000.00 | N/A | Maintains | 4 years ago |
Autolus Therapeutics PLCAUTL | 1 | Buy | $13.00 | N/A | Maintains | 5 years ago |
Immunomedics IncIMMU | 4 | Hold | $88.00 | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.